Antibiotice S.A. (BVB:ATB)

Antibiotice Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.35	2.68	1.81	1.73	2.11	6.33
Cash & Short-Term Investments	10.35	2.68	1.81	1.73	2.11	6.33
Cash Growth	-82.96%	48.31%	4.66%	-18.18%	-66.64%	237.14%
Accounts Receivable	399.9	275.39	221.13	196.51	269.76	252.9
Other Receivables	-	9.15	12.78	6.22	3.99	5.23
Receivables	399.9	284.54	233.91	202.73	273.75	258.13
Inventory	212.46	170.46	161.67	143.07	106.02	108.69
Prepaid Expenses	-	4.08	3.49	-	-	-
Other Current Assets	4.68	12.93	0.41	4.13	3.13	2.26
Total Current Assets	627.39	474.69	401.28	351.66	385.01	375.41
Property, Plant & Equipment	743.27	749.4	692.36	599.9	480.54	467.88
Other Intangible Assets	62.34	21.27	12.53	2.46	29.84	19.71
Long-Term Deferred Charges	-	33.9	33	30.29	-	-
Other Long-Term Assets	-	-	-	-	-	-0
Total Assets	1,433	1,279	1,139	984.32	895.39	863
Accounts Payable	-	83.5	73.66	65.4	66.32	42.46
Accrued Expenses	-	10.15	9.69	2.87	8.4	7.66
Short-Term Debt	258.36	57.58	32.44	34.01	87.16	95.57
Current Income Taxes Payable	-	-	-	-	9.61	11.19
Current Unearned Revenue	0.52	3.83	0.73	0.6	3.47	2.05
Other Current Liabilities	17.13	80	73.95	33.81	24.17	27.77
Total Current Liabilities	276.01	235.06	190.47	136.69	199.14	186.7
Long-Term Debt	145.52	85.72	36.75	46.97	57.62	65.44
Long-Term Unearned Revenue	10.26	5.15	1.59	1.86	2.16	2.47
Long-Term Deferred Tax Liabilities	61.78	59.03	63.4	57.82	31.48	31.12
Total Liabilities	493.57	384.95	292.21	243.34	290.4	285.73
Common Stock	67.13	67.13	67.13	67.13	67.13	67.13
Retained Earnings	664.51	613.23	554.41	476.09	-33.15	-35.34
Comprehensive Income & Other	207.78	213.95	225.42	197.76	571.01	545.47
Shareholders' Equity	939.43	894.31	846.96	740.98	604.99	577.27
Total Liabilities & Equity	1,433	1,279	1,139	984.32	895.39	863
Total Debt	403.88	143.29	69.19	80.98	144.78	161.01
Net Cash (Debt)	-393.53	-140.61	-67.38	-79.25	-142.67	-154.68
Net Cash Per Share	-0.59	-0.21	-0.10	-0.12	-0.21	-0.23
Filing Date Shares Outstanding	672.12	671.34	671.34	671.34	671.34	671.34
Total Common Shares Outstanding	672.12	671.34	671.34	671.34	671.34	671.34
Working Capital	351.38	239.64	210.81	214.97	185.87	188.71
Book Value Per Share	1.40	1.33	1.26	1.10	0.90	0.86
Tangible Book Value	877.09	873.04	834.44	738.52	575.15	557.56
Tangible Book Value Per Share	1.30	1.30	1.24	1.10	0.86	0.83
Land	-	204.79	204.79	203.67	189.93	189.93
Buildings	-	377.61	312.77	267.97	157.46	135.88
Machinery	-	344.5	296.48	271.21	234.38	204.77
Construction In Progress	-	20.57	42.67	9.09	64.71	81.82

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.